ORKA
Oruka Therapeutics, Inc.
79.50$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.4% | -3.1% | -7.8% | +1,123.5% | -4.4% | -4.8% | -5.2% | +42.5% | -4.1% | +3.2% | +125.9% | |
| – | -3.3% | -2.5% | -7.8% | +1,121.0% | -8.7% | -6.6% | -5.7% | +7.0% | -3.2% | +14.9% | +123.8% | |
| – | -2.7% | -4.1% | -7.3% | +1,134.5% | -85.0% | +35.7% | -21.7% | +39.5% | -48.6% | +5.5% | +442.1% | |
| – | -2.7% | -4.1% | -7.3% | +1,134.5% | -8.6% | -7.1% | -5.9% | +6.3% | -3.5% | +15.4% | +124.7% | |
| – | -30.8% | +88.0% | -19.6% | +5,543.0% | -80.8% | -10.2% | +11.2% | +63.0% | -25.7% | +6.4% | +39.9% | |
| – | -35.8% | +148.2% | -19.6% | +1,319.3% | -27.7% | -10.1% | +3.3% | +73.1% | -26.7% | +8.2% | +38.1% | |
| – | -1.3% | -36.8% | -50.0% | +508.3% | +45.9% | +32.9% | +133.2% | -36.5% | +47.7% | +9.9% | -1.6% | |
| – | – | – | +7.9% | +1,389.0% | -59.3% | +2.4% | +31.6% | -52.7% | +88.2% | -11.9% | +117.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.5% | -5.1% | -7.3% | +951.1% | +11.6% | -4.6% | -5.8% | +41.7% | -3.1% | +3.1% | +129.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.6% | +0.0% | +3.5% | +11.8% | +148.2% | +1.3% | +4.3% | +23.5% | +1.4% | +14.0% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.